168 related articles for article (PubMed ID: 9458580)
1. An interim determination of health gain from oral cancer and precancer screening: 2. Developing a model of population screening.
Downer MC; Jullien JA; Speight PM
Community Dent Health; 1997 Dec; 14(4):227-32. PubMed ID: 9458580
[TBL] [Abstract][Full Text] [Related]
2. An interim determination of health gain from oral cancer and precancer screening: 1. Obtaining health state utilities.
Downer MC; Jullien JA; Speight PM
Community Dent Health; 1997 Sep; 14(3):139-42. PubMed ID: 9332037
[TBL] [Abstract][Full Text] [Related]
3. An interim determination of health gain from oral cancer and precancer screening: 3. Preselecting high risk individuals.
Downer MC; Jullien JA; Speight PM
Community Dent Health; 1998 Jun; 15(2):72-6. PubMed ID: 9793221
[TBL] [Abstract][Full Text] [Related]
4. [A computer simulation of outcome in early screening studies of cancers of the mouth cavity].
Steinhart H
Laryngorhinootologie; 1994 Oct; 73(10):518-22. PubMed ID: 7802880
[TBL] [Abstract][Full Text] [Related]
5. Annual screening for oral cancer and precancer by invitation to 60-year-old residents of a city in Japan.
Ikeda N; Downer MC; Ishii T; Fukano H; Nagao T; Inoue K
Community Dent Health; 1995 Sep; 12(3):133-7. PubMed ID: 7584579
[TBL] [Abstract][Full Text] [Related]
6. Reliability of oral precancer screening by primary health care workers in Sri Lanka.
Warnakulasuriya S; Pindborg JJ
Community Dent Health; 1990 Mar; 7(1):73-9. PubMed ID: 2357611
[TBL] [Abstract][Full Text] [Related]
7. The evaluation and treatment of men with asymptomatic prostate nodules in primary care: a decision analysis.
Mold JW; Holtgrave DR; Bisonni RS; Marley DS; Wright RA; Spann SJ
J Fam Pract; 1992 May; 34(5):561-8. PubMed ID: 1578205
[TBL] [Abstract][Full Text] [Related]
8. Cost-effectiveness of organized versus opportunistic cervical cytology screening in Hong Kong.
Kim JJ; Leung GM; Woo PP; Goldie SJ
J Public Health (Oxf); 2004 Jun; 26(2):130-7. PubMed ID: 15284314
[TBL] [Abstract][Full Text] [Related]
9. Early findings from a community-based, cluster-randomized, controlled oral cancer screening trial in Kerala, India. The Trivandrum Oral Cancer Screening Study Group.
Sankaranarayanan R; Mathew B; Jacob BJ; Thomas G; Somanathan T; Pisani P; Pandey M; Ramadas K; Najeeb K; Abraham E
Cancer; 2000 Feb; 88(3):664-73. PubMed ID: 10649262
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness analysis of screening for lung cancer with low dose spiral CT (computed tomography) in the Australian setting.
Manser R; Dalton A; Carter R; Byrnes G; Elwood M; Campbell DA
Lung Cancer; 2005 May; 48(2):171-85. PubMed ID: 15829317
[TBL] [Abstract][Full Text] [Related]
11. Opportunistic screening for oral cancer and precancer in general dental practice: results of a demonstration study.
Lim K; Moles DR; Downer MC; Speight PM
Br Dent J; 2003 May; 194(9):497-502; discussion 493. PubMed ID: 12835785
[TBL] [Abstract][Full Text] [Related]
12. Reproducibility of an oral cancer and precancer detection program using a primary health care model in Sri Lanka.
Warnakulasuriya KA; Nanayakkara BG
Cancer Detect Prev; 1991; 15(5):331-4. PubMed ID: 1751941
[TBL] [Abstract][Full Text] [Related]
13. Characteristics of participants and non-participants in annual mass screening for oral cancer in 60-year-old residents of Tokoname city, Japan.
Ikeda N; Downer MC; Ozowa Y; Inoue C; Mizuno T; Kawai T
Community Dent Health; 1995 Jun; 12(2):83-8. PubMed ID: 7648416
[TBL] [Abstract][Full Text] [Related]
14. Reducing ovarian cancer mortality through screening: Is it possible, and can we afford it?
Havrilesky LJ; Sanders GD; Kulasingam S; Myers ER
Gynecol Oncol; 2008 Nov; 111(2):179-87. PubMed ID: 18722004
[TBL] [Abstract][Full Text] [Related]
15. Quality-adjusted life-years lack quality in pediatric care: a critical review of published cost-utility studies in child health.
Griebsch I; Coast J; Brown J
Pediatrics; 2005 May; 115(5):e600-14. PubMed ID: 15867026
[TBL] [Abstract][Full Text] [Related]
16. [Model program for screening oral cancers in the Roma population].
Csépe P; Bánóczy J; Dombi C; Forrai J; Gyenes M; Döbrossy L
Magy Onkol; 2007; 51(2):95-101. PubMed ID: 17660865
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness of treatment of early stage endometrial cancer.
Ashih H; Gustilo-Ashby T; Myers ER; Andrews J; Clarke-Pearson DL; Berry D; Berchuck A
Gynecol Oncol; 1999 Aug; 74(2):208-16. PubMed ID: 10419733
[TBL] [Abstract][Full Text] [Related]
18. Preventive health care, 1999 update: prevention of oral cancer mortality. The Canadian Task Force on Preventive Health Care.
Hawkins RJ; Wang EE; Leake JL
J Can Dent Assoc; 1999 Dec; 65(11):617. PubMed ID: 10859725
[TBL] [Abstract][Full Text] [Related]
19. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India.
Okonkwo QL; Draisma G; der Kinderen A; Brown ML; de Koning HJ
J Natl Cancer Inst; 2008 Sep; 100(18):1290-300. PubMed ID: 18780864
[TBL] [Abstract][Full Text] [Related]
20. Decision analysis of tamoxifen for the prevention of invasive breast cancer.
Grann VR; Sundararajan V; Jacobson JS; Whang W; Heitjan DF; Antman KH; Neugut AI
Cancer J; 2000; 6(3):169-78. PubMed ID: 10882333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]